Glucametacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C25H27ClN2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N1EXE5EHAN, chemically known as d-glucose, 2-(((1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indol-3-yl)acetyl)amino)-2-deoxy-, hydrate but generally known as glucametacin, which bears US NIH Compound Identifier 3033980. European Medicines Agency schedules Glucametacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07936MIG. The term GLUCAMETACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). GLUCAMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule glucametacin under HS 29339990 and SITC 51577. As of Q4 2014, GLUCAMETACIN remains the US FDA Preferred Term for this commodity. Glucametacin bears US NLM identifiers UMLS ID C0061377 and NCI Concept Code C80554. SMILES: CLC1CCC(C(=O)N2C(C(C3C2CCC(OC)C3)CC(=O)NC(C(O)C(O)C(O)CO)C=O)C)CC1.